These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 18847432)
1. [Therapeutic novelties in the management of arterial hypertension]. Santamaría Olmo R Nefrologia; 2008; 28 Suppl 5():131-7. PubMed ID: 18847432 [TBL] [Abstract][Full Text] [Related]
2. Aliskiren, the first approved renin inhibitor: Clinical application and safety in the treatment of hypertension. Riccioni G; Vitulano N; D'Orazio N; Bellocci F Adv Ther; 2009 Jul; 26(7):700-10. PubMed ID: 19649581 [TBL] [Abstract][Full Text] [Related]
3. [Is there a need for direct renin inhibitors?]. Grossman E Harefuah; 2008 Mar; 147(3):216-7, 278. PubMed ID: 18488862 [TBL] [Abstract][Full Text] [Related]
4. Improving microvascular outcomes in patients with diabetes through management of hypertension. McGill JB Postgrad Med; 2009 Mar; 121(2):89-101. PubMed ID: 19332966 [TBL] [Abstract][Full Text] [Related]
5. Managing cardiovascular and renal risk: the potential of direct renin inhibition. Sever PS; Gradman AH; Azizi M J Renin Angiotensin Aldosterone Syst; 2009 Jun; 10(2):65-76. PubMed ID: 19502253 [TBL] [Abstract][Full Text] [Related]
6. Aliskiren: new drug. Arterial hypertension: no evidence of clinical efficacy. Prescrire Int; 2008 Apr; 17(94):47-50. PubMed ID: 18516803 [TBL] [Abstract][Full Text] [Related]
7. Renin inhibitors: novel agents for renoprotection or a better angiotensin receptor blocker for blood pressure lowering? Pimenta E; Oparil S Cardiol Clin; 2008 Nov; 26(4):527-35. PubMed ID: 18929229 [TBL] [Abstract][Full Text] [Related]
8. Discordant effects of beta-blockade on central aortic systolic and brachial systolic blood pressure: considerations beyond the cuff. Epstein BJ; Anderson S Pharmacotherapy; 2007 Sep; 27(9):1322-33. PubMed ID: 17723086 [TBL] [Abstract][Full Text] [Related]
9. Aliskiren: an oral direct renin inhibitor for the treatment of hypertension. Sanoski CA Pharmacotherapy; 2009 Feb; 29(2):193-212. PubMed ID: 19170589 [TBL] [Abstract][Full Text] [Related]
16. An implantable carotid sinus baroreflex activating system: surgical technique and short-term outcome from a multi-center feasibility trial for the treatment of resistant hypertension. Tordoir JH; Scheffers I; Schmidli J; Savolainen H; Liebeskind U; Hansky B; Herold U; Irwin E; Kroon AA; de Leeuw P; Peters TK; Kieval R; Cody R Eur J Vasc Endovasc Surg; 2007 Apr; 33(4):414-21. PubMed ID: 17227715 [TBL] [Abstract][Full Text] [Related]
17. Under pressure: future prospects in hypertension management. Interview by Laura Dormer. Brunner HR Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):921-3. PubMed ID: 18666842 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic implications of recent megatrials in hypertension: in favor of new drugs. Volpe M; Tocci G J Nephrol; 2007; 20 Suppl 12():S12-8. PubMed ID: 18050137 [TBL] [Abstract][Full Text] [Related]
19. The current state of beta blockers in hypertension therapy. Lardizabal JA; Deedwania PC Indian Heart J; 2010; 62(2):111-7. PubMed ID: 21180299 [TBL] [Abstract][Full Text] [Related]
20. Expanding the opportunities for blocking the renin-angiotensin system: introduction to a special supplement. Weber MA Rev Cardiovasc Med; 2007; 8 Suppl 2():S1-6. PubMed ID: 17401311 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]